The role of the endocardium in the facilitatory effect of bradykinin on electrically-induced release of noradrenaline in rat cardiac ventricle

British Journal of Pharmacology

Volumn 118, Issue 2, 1996, Pages 364-368

  Vaz da silva, M ^a   Magina, S ^a   Domingues costa, A ^a   Moura, D ^a   Guimaraes S ^a  

^a Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

Angiotensin converting enzyme inhibitors; Bradykinin; Endocardium; Noradrenaline release; Rat ventricle; Receptors

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; NORADRENALIN; TRITIUM;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; ENDOCARDIUM; FACILITATION; HEART LEFT VENTRICLE; ISOTOPE LABELING; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT;

EID: 0029923249     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15411.x     Document Type: Article

References (32)

1. BAYDOUN, A.R., PEERS, S.H., CIRINO, G. & WOODWARD, B. (1989). Effects of endothelin 1 on the rat isolated heart. J. Cardiovasc. Pharmacol., 13 (Suppl 5), S193-S196.
2. BRUTSAERT, D.L., ANDRIES, L.J. (1992). The endocardial endothelium. Am. J. Physiol., 263, H985-H1002.
3. BRUTSAERT, D.L., MEULEMANS, A.L., SIPIDO, K.R. & SYS, S.U. (1988). Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ. Res., 62, 358-366.
4. CHULAK, C., COUTURE, R. & FOUCART S. (1995). Modulatory effects of bradykinin on the release of noradrenaline from rat isolated atria. Br. J. Pharmacol., 115, 330-334.
5. DENDORFER, A. & DOMINIAK, P. (1995). Characterization of bradykinin receptors mediating catecholamine release in PC12 cells. Naunyn-Schmied. Arch. Pharmacol., 351, 274-281.
6. DOHI, T., MORITA, K. & TSUJIMOTO, A. (1991). Presynaptic regulation of norepinephrine release by peptides in the peripheral nervous system. In Presynaptic Regulation of Neurotransmitter Release: A Handhook, ed. Feigenbaum, J. & Hanani, M. pp. 1117-1146. London: Freund Publishing House.
7. DUSTING, G.J., MONCADA, S. & VANE, J.R. (1977). Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid. Prostaglandins, 13, 3-15.
8. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
9. GUIMARÃES, S., ALBINO-TEIXEIRA, A. & PAIVA, M.Q. (1995). Hypertension and enhanced β-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors. Br. J. Pharmacol., 114, 1595-1598.
10. GUTMARÃES, S., BRANDÃO, F. & PAIVA, M.Q. (1978). A study of the adrenoceptor-mediated feedback mechanisms by using adrenaline as a false transmitter. Naunyn-Schmied. Arch. Pharmacol., 305, 185-188.
11. GUIMARÃES, S. & OSSWALD, W. (1969). Adrenergic receptors in the veins of the dog. Eur. J. Pharmacol., 5, 133-140.
12. HENDERSON, A.H., LEWIS, M.J., SHAH, A.M. & SMITH, J.A. (1992). Endothelium, endocardium, and cardiac contraction. Cardiovasc. Res., 26, 305-308.
13. ISHIKAWA, T., YANAGISAWA, M., KIMURA, S., GOTO, K. & MOSAKI, T. (1988). Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflügers Arch., 413, 108-110.
14. LEWIS, G.P. & REIT, E. (1965). The action of angiotensin and bradykinin on the superior ganglion of the cat. J. Physiol., 179, 538-553.
15. MINSHALL, R.D., YELAMANCHI, V.P., DJOKOVIC, A., MITELICH, D.J., ERDÖS, E.G., RABITO, S.F. & VOGEL, S.M. (1994). Importance of sympathetic innervation in the positive inotropic effects of bradykinin and ramiprilat. Circ. Res., 74, 441-447.
16. OSSWALD, W. & GUIMARÃES, S. (1983). Adrenergic mechanisms in blood vessels: morphological and pharmacological aspects. Rev. Physiol. Biochem. Pharmacol., 96, 53-122.
17. PALMER, R.M.J., FERRIGO, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 325, 524-525.
18. RAMACIOTTI, C., SHARKEY, A., MCCLELLAN, G. & WINEGRAD, S. (1992). Endothelial cells regulate cardiac contractility. Proc. Natl. Acad. Sci. U.S.A., 89, 4033-4036.
19. REGOLI, D. & BARABÉ, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
20. ROMAN, R.J. & HARDER, D.R. (1993). Cellular and ionic signal transduction mechanisms for the mechanical activation of renal vascular smooth muscle. J. Am. Soc. Nephrol., 4, 986-996.
21. RUMP, L.C., SCHAIBLE, U., BOHMANN, C., FRANKENSCHMIDT, A. & SCHOLLMEYER, P. (1995). Bradykinin facilitates noradrenaline release from human renal cortex in the presence of angiotensin converting enzyme inhibition. Br. J. Pharmacol., 114, 229P.
22. SEDAA, K.O., BJUR, R.A., SHINOZUKA, K. & WESTFALL, D.P. (1990). Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta. J. Pharmacol. Exp. Ther., 252, 1060-1067.
23. SHAH, A.M., SMITH, J.A. & LEWIS, M.J. (1991). The role of the endocardium in the modulation of contraction of isolated papillary muscle of the ferret. J. Cardiovasc. Pharmacol., 17, S251-S257.
24. SHINOZUKA, K., SEDAA, K.O., BJUR, R.A. & WESTFALL, D.P. (1991). Participation by purines in the modulation of norepinephrine release by methoxamine. Eur. J. Pharmacol., 192, 431-434.
25. SMITH, J.A., SHAH, A.M. & LEWIS, M.J. (1991). Factors released from endocardium of the ferret and pig modulate myocardial contraction. J. Physiol., 439, 1-14.
26. STARKE, K. (1977). Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol., 77, 1-124.
27. STARKE, K., PESKAR, B.A., SCHUMACHER, J.A. & TAUBE, H.D. (1977). Bradykinin and postganglionic sympathetic transmission. Naunyn-Schmied. Arch. Pharmacol., 299, 23-32.
28. TAKEUCHI, K., SHINOZUKA, K., AKIMOTO, H., ISHII, R. & HASHIMOTO, T. (1994). Methoxamine-induced release of endogenous ATP from rabbit pulmonary artery. Eur. J. Pharmacol., 254, 287-290.
29. TRENDELENBURG, U. (1966). Observations on the ganglion-stimulating action of angiotensin and bradykinin. J. Pharmacol. Exp. Ther., 154, 418-425.
30. VAN ROSSUM, J.M. (1963). Cumulative dose-response curves. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn., 143, 299-330.
31. 3H-noradrenaline release in the canine pulmonary artery. Naunyn-Schmied. Arch. Pharmacol., 352, 640-645.
32. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMBOE, Y., KOBAYASHI, M., MITSUAI, Y., YSAKI, Y., GOTO, K. & MASAKI, T. (1988). A novel vasoconstrictor peptide produced by vascular endothelial cells. Nature, 32, 411-415.